Skip to content
healthcare.dev

Doxazosin

NDC 16729-415, Doxazosin, tablet, from Accord Healthcare Inc..

Product NDC
16729-415
Status
Listed
Labeler
Accord Healthcare Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202824
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16729-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE8 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
16729-415-0116729041501100 TABLET in 1 BOTTLE (16729-415-01)
16729-415-17167290415171000 TABLET in 1 BOTTLE (16729-415-17)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2830533c-ccdf-4401-b19c-763eeb1bc0a7

Use it

Look up 16729-415 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16729-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16729-415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.